Maite Figueras

Author PubWeight™ 16.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome. Proc Natl Acad Sci U S A 2009 1.28
2 Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clin Nutr 2007 0.96
3 Effects of interleukin-15 on lipid oxidation: disposal of an oral [(14)C]-triolein load. Biochim Biophys Acta 2006 0.95
4 Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine. Biochim Biophys Acta 2006 0.94
5 Effects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARs. Obesity (Silver Spring) 2008 0.94
6 Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia. FEBS Lett 2005 0.90
7 Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells. Muscle Nerve 2008 0.88
8 Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. Clin Nutr 2007 0.84
9 Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists. Cancer Res 2007 0.82
10 PPARdelta mediates IL15 metabolic actions in myotubes: effects of hyperthermia. Int J Mol Med 2009 0.81
11 Interleukin-15 increases calcineurin expression in 3T3-L1 cells: possible involvement on in vivo adipocyte differentiation. Int J Mol Med 2009 0.81
12 Rat liver lipogenesis is modulated by interleukin-15. Int J Mol Med 2004 0.80
13 Sepsis induces DNA fragmentation in rat skeletal muscle. Eur Cytokine Netw 2004 0.80
14 [Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)]. Nutr Hosp 2006 0.79
15 Theophylline is able to partially revert cachexia in tumour-bearing rats. Nutr Metab (Lond) 2012 0.78
16 Targets in clinical oncology: the metabolic environment of the patient. Front Biosci 2007 0.77
17 Patterns of gene expression in muscle and fat in tumor-bearing rats: effects of CRF2R agonist on cachexia. Muscle Nerve 2010 0.77
18 Interleukin-15 decreases lipid intestinal absorption. Int J Mol Med 2005 0.77
19 Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting. Clin Nutr 2010 0.75
20 Effects of the PPARgamma agonist GW1929 on muscle wasting in tumour-bearing mice. Oncol Rep 2008 0.75
21 Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma. Anticancer Res 2009 0.75
22 A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation–contraction coupling together with additional muscle alterations. Muscle Nerve 2014 0.75